Group One Trading’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17
Closed -$196 8127
2022
Q4
$196 Buy
+17
New +$300 ﹤0.01% 7036
2022
Q3
Sell
-710
Closed -$17K 8429
2022
Q2
$17K Buy
710
+27
+4% +$919 ﹤0.01% 6428
2022
Q1
$34K Sell
683
-7,454
-92% -$368K ﹤0.01% 6403
2021
Q4
$571K Sell
8,137
-6,433
-44% -$542K ﹤0.01% 3973
2021
Q3
$1.36M Sell
14,570
-123
-0.8% -$11.7K ﹤0.01% 3065
2021
Q2
$1.48M Buy
14,693
+6,873
+88% +$670K ﹤0.01% 2959
2021
Q1
$730K Buy
7,820
+1,807
+30% +$183K ﹤0.01% 3600
2020
Q4
$496K Buy
6,013
+543
+10% +$46.3K ﹤0.01% 3271
2020
Q3
$469K Buy
5,470
+3,510
+179% +$409K ﹤0.01% 2908
2020
Q2
$182K Buy
1,960
+1,700
+654% +$93.7K ﹤0.01% 3459
2020
Q1
$7K Buy
260
+167
+180% +$6.49K ﹤0.01% 4695
2019
Q4
$4K Buy
+93
New +$2.04K ﹤0.01% 4809

Group One Trading's VBIV Position: Q3 2024 in Review

Group One Trading sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 4,001 shares — an estimated $2.64K sold.

Group One Trading first reported a position in VBIV in Q2 2019 and held it in 13 quarters. The position peaked at $805K in Q4 2021. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.

  • Group One Trading reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 4,001 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $2.64K.
  • Group One Trading first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2019 and held it in 13 quarters.
  • Group One Trading's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $805K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.